Works by Dey, Nandini

Results: 30

A CAF-Based Two-Cell Hybrid Co-Culture Model to Test Drug Resistance in Endometrial Cancers.

Published in:

Biomedicines, 2023, v. 11, n. 5, p. 1326, doi. 10.3390/biomedicines11051326

By:

Sulaiman, Raed;
De, Pradip;
Aske, Jennifer C.;
Lin, Xiaoqian;
Dale, Adam;
Gaster, Kris;
Espaillat, Luis Rojas;
Starks, David;
Dey, Nandini

Publication type:

Article

Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers.

Published in:

Biomedicines, 2023, v. 11, n. 1, p. 112, doi. 10.3390/biomedicines11010112

By:

Sulaiman, Raed;
De, Pradip;
Aske, Jennifer C.;
Lin, Xiaoqian;
Dale, Adam;
Koirala, Nischal;
Gaster, Kris;
Espaillat, Luis Rojas;
Starks, David;
Dey, Nandini

Publication type:

Article

RAC1 Takes the Lead in Solid Tumors.

Published in:

Cells (2073-4409), 2019, v. 8, n. 5, p. 382, doi. 10.3390/cells8050382

By:

De, Pradip;
Aske, Jennifer Carlson;
Dey, Nandini

Publication type:

Article

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive.

Published in:

Pharmaceuticals (14248247), 2021, v. 14, n. 5, p. 455, doi. 10.3390/ph14050455

By:

Nandini, Dey;
Jennifer, Aske;
Pradip, De;
Nakhjavani, Maryam;
Townsend, Amanda

Publication type:

Article

Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab‑refractory breast cancer model.

Published in:

2013

By:

Sun, Yuliang;
Dey, Nandini;
Brammer, Melissa;
De, Pradip;
Leyland-Jones, Brian

Publication type:

journal article

Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab-refractory breast cancer model.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 4, p. 733, doi. 10.1007/s00280-013-2233-7

By:

Sun, Yuliang;
Dey, Nandini;
Brammer, Melissa;
De, Pradip;
Leyland-Jones, Brian

Publication type:

Article

An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 867, doi. 10.1007/s00280-013-2078-0

By:

De, Pradip;
Dey, Nandini;
Terakedis, Breanne;
Bergsagel, P.;
Li, Zhi;
Mahadevan, Daruka;
Garlich, Joseph;
Trudel, Suzanne;
Makale, Milan;
Durden, Donald

Publication type:

Article

Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3441, doi. 10.3390/ijms25063441

By:

Sulaiman, Raed;
Dale, Adam;
Lin, Xiaoqian;
Aske, Jennifer C.;
Gaster, Kris;
Starks, David;
Espaillat, Luis Rojas;
De, Pradip;
Dey, Nandini

Publication type:

Article

Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial Cancers.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 11079, doi. 10.3390/ijms241311079

By:

Sulaiman, Raed;
De, Pradip;
Aske, Jennifer C.;
Lin, Xiaoqian;
Dale, Adam;
Koirala, Nischal;
Gaster, Kris;
Espaillat, Luis Rojas;
Starks, David;
Dey, Nandini

Publication type:

Article

Characterization and Clinical Relevance of Endometrial CAFs: Correlation between Post-Surgery Event and Resistance to Drugs.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6449, doi. 10.3390/ijms24076449

By:

Sulaiman, Raed;
De, Pradip;
Aske, Jennifer C.;
Lin, Xiaoqian;
Dale, Adam;
Gaster, Kris;
Espaillat, Luis Rojas;
Starks, David;
Dey, Nandini

Publication type:

Article

Targeting Cell Cycle Progression in HER2+ Breast Cancer: An Emerging Treatment Opportunity.

Published in:

2022

By:

Koirala, Nischal;
Dey, Nandini;
Aske, Jennifer;
De, Pradip

Publication type:

Literature Review

Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.

Published in:

International Journal of Molecular Sciences, 2021, v. 22, n. 17, p. 9121, doi. 10.3390/ijms22179121

By:

Pradip, De;
Jennifer, Aske;
Nandini, Dey

Publication type:

Article

Mutation-Driven Signals of ARID1A and PI3K Pathways in Ovarian Carcinomas: Alteration Is An Opportunity.

Published in:

International Journal of Molecular Sciences, 2019, v. 20, n. 22, p. 5732, doi. 10.3390/ijms20225732

By:

De, Pradip;
Dey, Nandini

Publication type:

Article

Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.

Published in:

2017

By:

Dey, Nandini;
Krie, Amy;
Klein, Jessica;
Williams, Kirstin;
McMillan, Amanda;
Elsey, Rachel;
Sun, Yuliang;
Williams, Casey;
De, Pradip;
Leyland-Jones, Brian

Publication type:

Case Study

Clinical Utility of Next-Generation Sequencing-Based Panel Testing under the Universal Health-Care System in Japan: A Retrospective Analysis at a Single University Hospital.

Published in:

Cancers, 2021, v. 13, n. 5, p. 1121, doi. 10.3390/cancers13051121

By:

Inagaki, Chiaki;
Maeda, Daichi;
Hatake, Kazue;
Sato, Yuki;
Hashimoto, Kae;
Sakai, Daisuke;
Yachida, Shinichi;
Nonomura, Iwao;
Satoh, Taroh;
Dey, Nandini;
De, Pradip

Publication type:

Article

Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR.

Published in:

Cancers, 2021, v. 13, n. 3, p. 458, doi. 10.3390/cancers13030458

By:

Dey, Nandini;
Aske, Jennifer;
De, Pradip;
Picard, Didier

Publication type:

Article

Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors.

Published in:

Cancers, 2020, v. 12, n. 6, p. 1541, doi. 10.3390/cancers12061541

By:

De, Pradip;
Rozeboom, Brett James;
Aske, Jennifer Carlson;
Dey, Nandini

Publication type:

Article

CSK Controls Retinoic Acid Receptor (RAR) Signaling: a RAR-c-SRC Signaling Axis Is Required for Neuritogenic Differentiation.

Published in:

Molecular & Cellular Biology, 2007, v. 27, n. 11, p. 26, doi. 10.1128/MCB.01352-06

By:

Dey, Nandini;
De, Pradip K.;
Mu Wang;
Hongying Zhang;
Dobrota, Erika A.;
Robertson, Kent A.;
Durden, Donald L.

Publication type:

Article

Triple Fluorescence staining to Evaluate Mechanism-based Apoptosis following Chemotherapeutic and Targeted Anti-cancer Drugs in Live Tumor Cells.

Published in:

Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-31575-3

By:

De, Pradip;
Carlson, Jennifer H.;
Leyland-Jones, Brian;
Williams, Casey;
Dey, Nandini

Publication type:

Article

Ex vivo platform en route to functional precision medicine: clinical relevance in gynecological cancers.

Published in:

American Journal of Cancer Research, 2024, v. 14, n. 6, p. 3083, doi. 10.62347/HTVU4235

By:

Sulaiman, Raed;
Aske, Jennifer C.;
Espaillat, Luis Rojas;
Xiaoqian Lin;
Starks, David;
Dale, Adam;
Gaster, Kris;
De, Pradip;
Dey, Nandini

Publication type:

Article

A landscape of patient-derived cancer-associated fibroblast signals in endometrial cancers.

Published in:

American Journal of Cancer Research, 2024, v. 14, n. 2, p. 467, doi. 10.62347/NJRZ3602

By:

Sulaiman, Raed;
Koirala, Nischal;
Aske, Jennifer C.;
Lin, Xiaoqian;
Rojas-Espaillat, Luis;
Starks, David;
Dale, Adam;
Gaster, Kris;
De, Pradip;
Dey, Nandini

Publication type:

Article

Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial Cancers.

Published in:

Cancers, 2022, v. 14, n. 19, p. 4577, doi. 10.3390/cancers14194577

By:

Sulaiman, Raed;
De, Pradip;
Aske, Jennifer C.;
Lin, Xiaoqian;
Dale, Adam;
Vaselaar, Ethan;
Ageton, Cheryl;
Gaster, Kris;
Espaillat, Luis Rojas;
Starks, David;
Dey, Nandini

Publication type:

Article

Precision Medicine in Solid Tumors: How Far We Traveled So Far?

Published in:

2022

By:

Dey, Nandini;
De, Pradip

Publication type:

Editorial

A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-Immunofluorescence.

Published in:

Cancers, 2022, v. 14, n. 12, p. 2871, doi. 10.3390/cancers14122871

By:

Sulaiman, Raed;
De, Pradip;
Aske, Jennifer C.;
Lin, Xiaoqian;
Dale, Adam;
Vaselaar, Ethan;
Koirala, Nischal;
Ageton, Cheryl;
Gaster, Kris;
Plorde, Joshua;
Solomon, Benjamin;
Thaemert, Bradley;
Meyer, Paul;
Espaillat, Luis Rojas;
Starks, David;
Dey, Nandini

Publication type:

Article

Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.

Published in:

Cancers, 2022, v. 14, n. 6, p. 1519, doi. 10.3390/cancers14061519

By:

De, Pradip;
Aske, Jennifer;
Sulaiman, Raed;
Dey, Nandini

Publication type:

Article

Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy.

Published in:

Cancers, 2021, v. 13, n. 20, p. 5246, doi. 10.3390/cancers13205246

By:

De, Pradip;
Aske, Jennifer;
Dey, Nandini

Publication type:

Article

Wnt signaling in triple negative breast cancer is associated with metastasis.

Published in:

BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-537

By:

Dey, Nandini;
Barwick, Benjamin G.;
Moreno, Carlos S.;
Ordanic-Kodani, Maja;
Zhengjia Chen;
Oprea-Ilies, Gabriella;
Weining Tang;
Catzavelos, Charles;
Kerstann, Kimberly F.;
Sledge Jr., George W.;
Abramovitz, Mark;
Bouzyk, Mark;
De, Pradip;
Leyland-Jones, Brian R.

Publication type:

Article

Wnt signaling in triple negative breast cancer is associated with metastasis.

Published in:

2013

By:

Dey, Nandini;
Barwick, Benjamin G;
Moreno, Carlos S;
Ordanic-Kodani, Maja;
Chen, Zhengjia;
Oprea-Ilies, Gabriella;
Tang, Weining;
Catzavelos, Charles;
Kerstann, Kimberly F;
Sledge Jr, George W;
Abramovitz, Mark;
Bouzyk, Mark;
De, Pradip;
Leyland-Jones, Brian R;
Sledge, George W Jr

Publication type:

journal article

Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner.

Published in:

PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077425

By:

Dey, Nandini;
Young, Brandon;
Abramovitz, Mark;
Bouzyk, Mark;
Barwick, Benjamin;
De, Pradip;
Leyland-Jones, Brian

Publication type:

Article

Promise of Precision Medicine in Cancers: Lessons Learned.

Published in:

South Dakota Medicine, 2017, v. 70, n. 11, p. 486

By:

Dey, Nandini;
Williams, Casey;
Leyland-Jones, Brian;
De, Pradip

Publication type:

Article